Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WorldHeart plans VAD study at 10 U.S. centers

This article was originally published in The Gray Sheet

Executive Summary

FDA grants conditional approval for a U.S. bridge-to-transplant study of WorldHeart's Levacor ventricular assist device, a bearingless, fully magnetically levitated, implantable centrifugal pump. The Salt Lake City, Utah, firm says Aug. 20 that it is awaiting institutional review board approval at 10 clinical centers in the U.S.; WorldHeart eventually hopes to expand the study to 200 subjects

Related Content

Research In Brief





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts